

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CTLT | NYSE | USD | Real-time | |
0C8 | Frankfurt | EUR | Delayed | |
CTLT-RM | Moscow | RUB | Real-time |
Equity markets in Europe, the US, and Asia had a positive week, with S&P 500 and Nasdaq performing well. 0DTE options, which are cheap and offer a way to bet on short-term volatility, have sparked...
Last week’s stock market rally had a few anomalies that investors should cast a wary eye on. The main oddity saw investors pull billions of dollars out of two of the biggest U.S.-traded equity funds:...
Last August, a little section of U.S. President Joe Biden’s much-touted Inflation Reduction Act caught the attention of investors. It introduced a 1% tax on stock buybacks. Most companies and...
The COVID-19 pandemic highlighted the importance of health care and the role biopharma companies play in drug and vaccine development. As a result, the sector grew tremendously during the past 2...
Shares of McKesson Corporation (NYSE:MCK) MCK scaled a new 52-week high of $258.28 on Jan 28, before closing the session marginally lower at $258.21.Over the past year, this Zacks Rank #3 (Hold) stock...
Masimo (NASDAQ:MASI) Corporation MASI announced preliminary financial results for full-year 2021 on Jan 11. Following this release, shares of the company are down 0.5% till the last trading.The...
Moderna (NASDAQ:MRNA), Inc. MRNA and the newly founded manufacturing and technology company, National Resilience, Inc. (Resilience), signed a multi-year agreement for manufacturing of the drug...
Catalent (NYSE:CTLT), Inc. CTLT has been gaining on the back of its slew of strategic deals over the past few months. A robust third-quarter fiscal 2021 performance, along with integrated development...
PerkinElmer (NYSE:PKI), Inc. PKI reported second-quarter 2021 adjusted earnings per share (EPS) of $2.83, which beat the Zacks Consensus Estimate of $2.41 per share by 17.4%. The bottom line improved...
A few large pharma companies have already reported their fourth-quarter results. Johnson & Johnson JNJ and Eli Lilly (NYSE:LLY) surpassed estimates for both earnings and sales in the fourth...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review